Market Cap

CollPlant Biotechnologies Ltd. Market Capitalization:

$70.4 Million

USD as of Jan. 1, 2024

business CollPlant Biotechnologies Ltd. Company Profile

CollPlant Biotechnologies Ltd. Main Stock Listing

NASDAQ: CLGN

Market Capitalization History of CollPlant Biotechnologies Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of CollPlant Biotechnologies Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $70.4 M -25.56%
Jan. 1, 2023 $94.6 M -1.43%
Jan. 1, 2022 $96.0 M -46.10%
Jan. 1, 2021 $178.1 M 73.36%
Jan. 1, 2020 $102.7 M 75.17%
Jan. 1, 2019 $58.6 M -32.96%
Jan. 1, 2018 $87.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

CollPlant Biotechnologies Ltd. Categories

Israel languages Healthcare languages Biotechnology
Israel Healthcare Israel Biotechnology

Stocks & Indices

CollPlant Biotechnologies Ltd. has the following listings and related stock indices.


Stock: NASDAQ: CLGN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.